Indo amines Limited has announced the resignation of Mr. Vijay Yeshwant Sane from his position as Independent Director, effective April 16, 2026. The company informed both BSE and NSE about this board change through a regulatory filing dated April 17, 2026, in compliance with SEBI listing regulations.

Director Resignation Details

The resignation was formalized through Mr. Sane's letter dated April 16, 2026, addressed to the Board of Directors. The following table summarizes the key details of the directorship change:

Reason for Departure

In his resignation letter, Mr. Sane explained that he was stepping down due to pre-occupation elsewhere, which would prevent him from fulfilling his responsibilities and duties toward the company. He specifically stated that he "wouldn't be able to tender my responsibilities/duties towards the Company" and requested immediate relief from his directorial duties.

Regulatory Compliance

The company has fulfilled all regulatory requirements under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Key compliance aspects include:

• Filing under Regulation 30 of SEBI Listing Regulations
• Compliance with Schedule III requirements
• Adherence to SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
• Submission of resignation letter with detailed reasons

Director's Confirmation

Mr. Sane has provided written confirmation that there are no other material reasons for his resignation beyond those mentioned in his resignation letter. This confirmation is a mandatory requirement under SEBI regulations for independent director resignations. The director also confirmed that he holds no directorships in other listed entities.

Administrative Process

The resignation was processed by Company Secretary and Compliance Officer Tripti Sawant (Membership No: A39926), who signed the regulatory filing on April 17, 2026. The company has committed to submitting necessary forms with concerned authorities and maintaining proper records of the directorship change.

Indo amines Limited has informed stock exchanges about a significant change in its corporate structure, with subsidiary Indo Speciality Chemicals Private Limited transitioning to associate company status following a rights issue dilution. The change occurred on March 30, 2026, after Indo Amines chose not to participate in its subsidiary's rights offering.

Shareholding Structure Changes

The non-participation in the rights issue resulted in a dilution of Indo Amines' stake in Indo Speciality Chemicals, though the absolute number of shares remained unchanged. The company provided detailed information about the ownership transition:

Regulatory Compliance Details

In compliance with Regulation 30 of SEBI LODR requirements, Indo Amines disclosed comprehensive details of the transaction. The company clarified that no consideration was received as part of this change, and no acquisition cost was involved since the dilution occurred through non-participation rather than active divestment.

Impact Assessment

The management emphasized that the impact of this structural change remains limited in scope. Key aspects of the transition include:

• Operational Impact: No material effect on overall company operations
• Financial Consideration: No monetary transaction involved
• Strategic Influence: Continued significant influence despite reduced ownership
• Classification Change: Formal reclassification from subsidiary to associate company status

Corporate Governance Implications

The change represents a shift in corporate governance structure while maintaining business relationships. Despite the reduced shareholding percentage, Indo Amines retains substantial influence in Indo Speciality Chemicals through its 39.39% stake. This transition reflects the company's strategic approach to capital allocation and subsidiary management.

The announcement was signed by Company Secretary and Compliance Officer Tripti Sawant, ensuring proper regulatory disclosure and maintaining transparency with stakeholders regarding this corporate restructuring development.